Abstract
The expanded scope of the Medicaid program has accomplished a great deal in bolstering substance use treatment, but further progress will depend on correcting deficiencies in non‐expansion states and within Medicaid managed care entities, a newly published commentary suggests.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have